CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- Open-market buys, last 90 days
- $22,023,904
- in 7 filings
- Open-market sales, last 90 days
- $4,490,340
- in 8 filings, $4.5M under 10b5-1 plans
Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | HEALY JAMES Director | Purchase | +2,748 | $26.06 | $72K | 33,114 |
| 2024-07-01 | HEALY JAMES Director | Purchase | +3,630 | $23.08 | $84K | 29,908 |
| 2024-07-01 | HEALY JAMES Director | Purchase | +3,657 | $24.21 | $89K | 33,565 |
| 2024-07-01 | HEALY JAMES Director | Purchase | +4,661 | $25.02 | $117K | 38,226 |
| 2024-07-01 | HEALY JAMES Director | Purchase | +2,625 | $26.06 | $68K | 40,851 |
| 2024-06-10 | ARCH Venture Partners XII, LLC 10% owner | Conversion | +3,728,738 | 3,728,738 | ||
| 2024-06-10 | ARCH Venture Partners XII, LLC 10% owner | Conversion · Series A Preferred Stock | −20,000,000 | 0 | ||
| 2024-06-10 | ARCH Venture Partners XII, LLC 10% owner | Conversion · Series B Preferred Stock | −11,924,138 | 0 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion | +6,551,449 | 7,135,233 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion | +969,218 | 969,218 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −56,091,177 | 0 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −8,000,000 | 0 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series B Preferred Stock | −298,103 | 0 | ||
| 2024-06-10 | HEALY JAMES Director | Conversion | +1,392,738 | 1,392,738 | ||
| 2024-06-10 | HEALY JAMES Director | Purchase | +470,589 | $17.00 | $8.0M | 1,863,327 |
| 2024-06-10 | HEALY JAMES Director | Purchase | +18,641 | $17.00 | $317K | 18,641 |
| 2024-06-10 | HEALY JAMES Director | Purchase | +17,861 | $17.00 | $304K | 17,861 |
| 2024-06-10 | HEALY JAMES Director | Purchase | +26,278 | $17.00 | $447K | 26,278 |
| 2024-06-10 | HEALY JAMES Director | Purchase | +25,455 | $17.00 | $433K | 25,455 |
| 2024-06-10 | HEALY JAMES Director | Conversion · Series B Preferred Stock | −11,924,138 | 0 |
Page 9 of 10 · 186 trades